SOLITRON DEVICES INC 8K

Solitron Devices, Inc. set its April 24, 2026 annual meeting date and launched a strategic review to explore potential merger, sale, acquisition, tender offer, or special dividend opportunities after a prior unsolicited acquisition proposal did not progress to a transaction.

Solitron Devices, Inc. announced that its board of directors has scheduled the company’s annual meeting for April 24, 2026 and has initiated a strategic review to explore potential transactions, including a merger, sale of the company or a subsidiary, acquisitions, a tender offer, or a special dividend, following the lapse of exclusivity on an unsolicited non-binding acquisition proposal that was not finalized. The company highlighted record backlog of $28.3 million as of January 31, 2026, strong demand tied to key defense programs such as AMRAAM, HIMARS, SM2, and SM6, and stated its belief that the current stock price undervalues the business. While it has not yet retained an investment banker, Solitron is inviting interested parties to contact the company and indicates it will set up a data room, but cautions there is no assurance that the review will result in any transaction or shareholder distribution, and it does not intend to provide further updates unless a specific transaction or other disclosable course of action is approved.

Filing Facts

CIK

91668

Ticker

-

Form

8K

Source Type

fda

Accession

0001437749-26-002816

Alert Tier

7